C12N 2501/12
Hepatocyte growth factor [hgf]
Official title: Hepatocyte growth factor [HGF]
C12N2501/12 (Hepatocyte growth factor [hgf]) appears on 256 US grants and 557 published applications in this corpus.
Search patents in C12N- Granted patents
- 256
- Published applications
- 557
- Assignees
- 315
- Inventors
- 1,006
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 4 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 9 |
| 2003 | 5 | 8 |
| 2004 | 2 | 19 |
| 2005 | 1 | 22 |
| 2006 | 5 | 25 |
| 2007 | 5 | 17 |
| 2008 | 5 | 17 |
| 2009 | 11 | 18 |
| 2010 | 5 | 19 |
| 2011 | 9 | 23 |
| 2012 | 11 | 17 |
| 2013 | 11 | 18 |
| 2014 | 7 | 18 |
| 2015 | 13 | 17 |
| 2016 | 13 | 25 |
| 2017 | 15 | 25 |
| 2018 | 14 | 20 |
| 2019 | 18 | 25 |
| 2020 | 17 | 32 |
| 2021 | 13 | 27 |
| 2022 | 13 | 30 |
| 2023 | 12 | 40 |
| 2024 | 14 | 34 |
| 2025 | 17 | 29 |
| 2026 | 10 | 23 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Generation of uniform hepatocytes from human embryonic stem cells by inhibiting TGF-beta and methods of maintaining hepatic cultures15 Sep 2026US 12,734,197 B2Wisconsin Alumni Research Foundation
- Method for culturing gynaecological tumour primary cells and matching culture medium25 Aug 2026US 12,716,057 B2Genex Health Co., Ltd
- Proliferative liver organoid, metabolically activated liver organoid, and use thereof14 Jul 2026US 12,680,080 B2Jsr Corporation
- Biocompatible conditioned cell medium compositions and uses thereof16 Jun 2026US 12,655,384 B2Cellum Biomedical, Inc.
- Liver organoid, uses thereof and culture method for obtaining them9 Jun 2026US 12,649,903 B2Koninklijke Nederlandse Akademie van Wetenschappen
- Methods and compositions related to platelet releasate and platelet-rich fibrin8 Oct 2026US 2026/0306546 A1Biobridge Global
- Culture media and conditions for in vitro expansion and/or maturation of hepatocytes24 Sep 2026US 2026/0286311 A1Satellite Biosciences, Inc.
- Liver disease regulatory formulation and use thereof27 Aug 2026US 2026/0248860 A1Shanghai Celliver Biotechnology Co., Ltd.
- A method for producing a bioengineered mammal induced pluripotent stem cell-derived cardiac organoid27 Aug 2026US 2026/0250636 A1Assistance Publique-HôPitaux De Paris (Aphp)
- Method for direct transdifferentiation of somatic cell2 Jul 2026US 2026/0185053 A1Juntendo Educational Foundation
Most cited
By later US patents
- Hepatocyte lineage cells derived from pluripotent stem cells175US 6,458,589 B1Geron Corporation · 2002
- Treatment of retinitis pigmentosa with human umbilical cord cells175US 7,413,734 B2Ethicon, Inc. · 2008
- Endoderm cells from human embryonic stem cells169US 7,326,572 B2Geron Corporation · 2008
- Methods of producing pancreatic hormones165US 7,534,608 B2Cythera, Inc. · 2009
- Islet cells from human embryonic stem cells152US 7,033,831 B2Geron Corporation · 2006